Division of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA.
J Neurosci. 2010 Oct 13;30(41):13814-25. doi: 10.1523/JNEUROSCI.1943-10.2010.
Systemic exposure to nicotine induces glutamatergic synaptic plasticity on dopamine (DA) neurons in the ventral tegmental area (VTA), but mechanisms are largely unknown. Here, we report that single, systemic exposure in rats to nicotine (0.17 mg/kg free base) increases the ratio of DA neuronal currents mediated by AMPA relative to NMDA receptors (AMPA/NMDA ratio) assessed 24 h later, based on slice-patch recording. The AMPA/NMDA ratio increase is evident within 1 h and lasts for at least 72 h after nicotine exposure (and up to 8 d after repeated nicotine administration). This effect cannot be prevented by systemic injection of either α7-nAChR (nicotinic ACh receptor)-selective [methyllycaconitine (MLA)] or β2*-nAChR-selective [mecamylamine (MEC)] antagonists but is prevented by coinjection of MLA and MEC. In either nAChR α7 or β2 subunit knock-out mice, systemic exposure to nicotine still increases the AMPA/NMDA ratio. Preinjection in rats of a NMDA receptor antagonist MK-801((+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate), but neither DA receptor antagonists [SCH-23390 (R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine) plus haloperidol] nor a calcineurin inhibitor (cyclosporine), prevents the nicotine-induced increase in AMPA/NMDA ratio. After systemic exposure to nicotine, glutamatergic (but not GABAergic) transmission onto rat VTA DA neuronal inputs is enhanced. Correspondingly, DA neuronal firing measured 24 h after nicotine exposure using extracellular single-unit recording in vivo is significantly faster, and there is conversion of silent to active DA neurons. Collectively, these findings demonstrate that systemic nicotine acting via either α7- or β2*-nAChRs increases presynaptic and postsynaptic glutamatergic function, and consequently initiates glutamatergic synaptic plasticity, which may be an important, early neuronal adaptation in nicotine reward and reinforcement.
系统暴露于尼古丁会在腹侧被盖区(VTA)的多巴胺(DA)神经元上诱导谷氨酸能突触可塑性,但机制在很大程度上尚不清楚。在这里,我们报告在大鼠中单次全身暴露于尼古丁(0.17mg/kg 游离碱)会增加 24 小时后通过切片贴记录评估的 DA 神经元电流介导的 AMPA 相对于 NMDA 受体(AMPA/NMDA 比)的比值。这种 AMPA/NMDA 比的增加在接触尼古丁后 1 小时内明显,并持续至少 72 小时(甚至在重复给予尼古丁后 8 天)。这种效应不能通过全身注射α7-nAChR(烟碱型乙酰胆碱受体)选择性[甲基-lycaconitine(MLA)]或β2*-nAChR 选择性[mecamylamine(MEC)]拮抗剂来预防,但可以通过 MLA 和 MEC 的共注射来预防。在 nAChR α7 或β2 亚单位敲除小鼠中,全身暴露于尼古丁仍会增加 AMPA/NMDA 比值。在大鼠中预先注射 NMDA 受体拮抗剂 MK-801((+)-5-甲基-10,11-二氢-5H-二苯并[a,d]环庚烯-5,10-亚胺马来酸盐),但既不是 DA 受体拮抗剂[SCH-23390(R-(+)-7-氯-8-羟基-3-甲基-1-苯基-2,3,4,5-四氢-1H-3-苯并氮杂卓)加氟哌啶醇]也不是钙调神经磷酸酶抑制剂(环孢素),可预防尼古丁诱导的 AMPA/NMDA 比值增加。全身接触尼古丁后,谷氨酸能(而非 GABA 能)传入到大鼠 VTA DA 神经元的传递增强。相应地,在体内使用细胞外单位记录在尼古丁暴露 24 小时后测量的 DA 神经元放电明显更快,并且沉默的 DA 神经元转化为活跃的 DA 神经元。总的来说,这些发现表明,系统内的尼古丁通过α7-或β2*-nAChR 作用增加了突触前和突触后的谷氨酸能功能,从而引发了谷氨酸能突触可塑性,这可能是尼古丁奖赏和强化中的一个重要的早期神经元适应。